Research Paper Volume 15, Issue 8 pp 3035—3051

TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process

class="figure-viewer-img"

Figure 1. TYRO3 expression in 120 CRC and paired normal tissues. (A) Representative IHC images showing TYRO3 expression in CRC and paired normal tissues (scale bar = 100 μm). (B) TYRO3 positive ratio in tumor tissues and normal tissues. (C, D) IHC scores of TYRO3 in (C) tumor versus normal tissues, and (D) TNM stage I-II versus stage III-IV. (E) Overall survival analysis of TYRO3pos versus TYRO3neg CRC patients. (F) In subgroup of TNM staging I-II, overall survival analysis of TYRO3pos versus TYRO3neg CRC patients.